Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
855.7 USD | +2.20% | +3.48% | +45.63% |
12:08pm | Jefferies Adjusts Price Target on Eli Lilly to $957 From $925 | MT |
08:15am | US FDA Staff Flags Potential Limited Benefit of Eli Lilly's Alzheimer's Disease Drug | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.63% | 754B | |
+40.95% | 630B | |
-6.49% | 352B | |
+19.86% | 331B | |
+8.64% | 298B | |
+18.66% | 250B | |
+11.99% | 217B | |
-0.53% | 216B | |
+6.09% | 164B | |
+0.03% | 163B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Transcript : Eli Lilly and Company Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-28-2023 03